Evidence map›Paper›PMID 30379870›Full record

ArticlePloS one2018

Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France.

Laure-Amélie de Monteynard, Sophie Matheron, Sophie Grabar, Pierre de Truchis, Jacques Gilquin, Juliette Pavie, Odile Launay, Jean-Luc Meynard, Marie-Aude Khuong-Josses, David Rey and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Laure-Amélie de MonteynardSorbonne Universités, UPMC Université Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
Sophie MatheronSorbonne Paris cité, Université Paris Diderot, UMR 1137, Paris, France.
Sophie GrabarSorbonne Universités, UPMC Université Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
Pierre de TruchisAP-HP, Hôpitaux Universitaires Paris-Ile de France-Ouest, Hôpital Raymond-Poincaré, Département de Médecine Aigüe Spécialisée, Garches, France.
Jacques GilquinAP-HP, Hôpital Hôtel-Dieu, Unité d'immunoinfectiologie, Paris, France.
Juliette PavieAP-HP, Hôpital Européen Georges Pompidou, Service d'immunologie clinique, Paris, France.
Odile LaunayUniversité Paris Descartes, Sorbonne Paris cité, Paris, France.
Jean-Luc MeynardAP-HP, Hôpital Saint Antoine, Service des Maladies Infectieuses et Tropicales, Paris, France.
Marie-Aude Khuong-JossesCentre Hospitalier Saint-Denis, Hôpital Delafontaine, Service des Maladies Infectieuses et Tropicales, Saint-Denis, France.
David ReyHôpitaux Universitaire Strasbourg, Centre de Soins de l'Infection par le VIH, Strasbourg, France.
Aba MahamatCentre Hospitalier Andrée Rosemon, Service des Maladies Infectieuses et Tropicales, Cayenne, France.
Rosemarie Dray-SpiraSorbonne Universités, UPMC Université Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
Anne SimonAP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de médecine interne, Paris, France.
Dominique CostagliolaSorbonne Universités, UPMC Université Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
Sophie AbgrallSorbonne Universités, UPMC Université Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.ORCID 0000-0002-7891-7594
FHDH-ANRS CO4
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRDélégation Paris 5 · FRSorbonne Université · FRCentre Hospitalier Saint-Denis · FRHôpitaux Universitaires de Strasbourg · FRUniversité Claude Bernard Lyon 1 · FRUniversity of French Guiana · GF

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe influence of geographic origin on the risk of severe illness and death on cART has not been explored in European countries.

methodWe studied antiretroviral-naïve heterosexual HIV-1-infected individuals enrolled in the FHDH-ANRS CO4 cohort in France who started cART between 2006 and 2011. Individuals originating from France (French natives), sub-Saharan Africa (SSA) and non-French West-Indies (NFW) were studied until 2012. Crude and adjusted rate ratios (aRR) of severe morbid events/deaths (AIDS-related and non-AIDS-related) were calculated using Poisson regression models stratified by sex, comparing each group of migrants to French natives.

resultsAmong 2334 eligible men, 1379 (59.1%) originated from France, 838 (35.9%) from SSA and 117 (5.0%) from NFW. SSA male migrants had a higher aRR for non-AIDS infections, particularly bacterial infections (aRR 1.56 (95% CI 1.07-2.29), p = 0.0477), than French natives. Among 2596 eligible women, 1347 (51.9%) originated from France, 1131 (43.6%) from SSA, and 118 (4.5%) from NFW. SSA and NFW female migrants had a higher aRR for non-AIDS infections, particularly non-bacterial infections (respectively, 2.04 (1.18-3.53) and 7.87 (2.54-24.4), p = 0.0010), than French natives. We observed no other significant differences related to geographic origin as concerns the aRRs for AIDS-related infections or malignancies, or for other non-AIDS events/deaths such as cardiovascular disease, neurological/psychiatric disorders, non-AIDS malignancies and iatrogenic disorders, in either gender.

conclusionHeterosexual migrants from SSA or NFW living in France have a higher risk of non-AIDS-defining infections than their French native counterparts. Special efforts are needed to prevent infectious diseases among HIV-infected migrants.

Indexed as

Acquired Immunodeficiency SyndromeAdultAfrica South of the SaharaAnti-Retroviral AgentsDatabases, FactualDrug Therapy, CombinationFemaleFranceHeterosexualityHIV InfectionsHumansIncidenceMaleMiddle AgedMorbidityPoisson DistributionAnti-Retroviral Agents

Identifiers

PMID30379870
PMCPMC6209163
OpenAlexW2898695975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.